|
|
PUT
|
$0
|
62.5K
|
Q3 2024
Added 388.28%
|
|
|
|
CALL
|
$0
|
143K
|
Q3 2024
Added 126.74%
|
|
|
|
PUT
|
$0
|
61.8K
|
Q3 2024
Added 55.67%
|
|
|
|
CALL
|
$0
|
50.9K
|
Q3 2024
Added 3.67%
|
|
|
|
PUT
|
$0
|
39.8K
|
Q3 2024
Added 5.01%
|
|
|
|
CALL
|
$0
|
2.5K
|
Q3 2024
Added 108.33%
|
|
|
|
PUT
|
$0
|
13.7K
|
Q3 2024
Reduced 2.84%
|
|
|
|
CALL
|
$0
|
4K
|
Q3 2024
Added 3900.0%
|
|
|
|
CALL
|
$0
|
44.8K
|
Q3 2024
Added 264.23%
|
|
|
|
PUT
|
$0
|
200
|
Q3 2024
Reduced 60.0%
|
|
|
|
CALL
|
$0
|
16.9K
|
Q3 2024
Added 87.78%
|
|
|
|
CALL
|
$0
|
26.7K
|
Q3 2024
Added 79.19%
|
|
|
|
PUT
|
$0
|
3.6K
|
Q3 2024
Reduced 30.77%
|
|
Academy Sports & Outdoors In
|
CALL
|
$0
|
4.5K
|
Q3 2024
Reduced 16.67%
|
|
Academy Sports & Outdoors In
|
PUT
|
$0
|
10K
|
Q3 2024
Reduced 69.88%
|
|
Acadia Healthcare Company In
|
CALL
|
$0
|
71.1K
|
Q3 2024
Added 23600.0%
|
|
Acadia Healthcare Company In
|
PUT
|
$0
|
21.6K
|
Q3 2024
Added 28.57%
|
|
Acadia Pharmaceuticals Inc
|
CALL
|
$0
|
41.8K
|
Q3 2024
Added 39.33%
|
|
Acadia Pharmaceuticals Inc
|
PUT
|
$0
|
57.4K
|
Q3 2024
Added 30.16%
|
|
|
|
CALL
|
$0
|
10K
|
Q3 2024
New holding
|
|
|
|
CALL
|
$0
|
57.9K
|
Q3 2024
Added 15.8%
|
|
|
|
PUT
|
$0
|
115K
|
Q3 2024
Reduced 47.25%
|
|
|
|
CALL
|
$0
|
500
|
Q3 2024
Reduced 93.33%
|
|
|
|
CALL
|
$0
|
2K
|
Q2 2024
Reduced 86.21%
|
|
|
|
CALL
|
$0
|
3.4K
|
Q3 2024
Reduced 10.53%
|
|
|
|
PUT
|
$0
|
4.9K
|
Q3 2024
New holding
|
|
Achieve Life Sciences Inc
|
CALL
|
$0
|
150K
|
Q3 2024
Reduced 18.12%
|
|
Achieve Life Sciences Inc
|
PUT
|
$0
|
16.9K
|
Q3 2024
Reduced 15.5%
|
|
|
|
CALL
|
$0
|
8K
|
Q3 2024
Added 321.05%
|
|
|
|
CALL
|
$0
|
15.9K
|
Q3 2024
Added 2550.0%
|
|
|
|
PUT
|
$0
|
2.3K
|
Q3 2024
Added 4.55%
|
|
Actinium Pharmaceuticals Inc
|
CALL
|
$0
|
9.7K
|
Q3 2024
Added 29.33%
|
|
Acumen Pharmaceuticals Inc
|
CALL
|
$0
|
21.4K
|
Q3 2024
Reduced 62.72%
|
|
Acumen Pharmaceuticals Inc
|
PUT
|
$0
|
132K
|
Q3 2024
Added 4.53%
|
|
Acurx Pharmaceuticals Inc
|
PUT
|
$0
|
1.3K
|
Q3 2024
Reduced 74.51%
|
|
Adaptive Biotechnologies Cor
|
CALL
|
$0
|
9K
|
Q3 2024
Reduced 43.75%
|
|
Adaptimmune Therapeutics PLC
|
CALL
|
$0
|
35.1K
|
Q3 2024
Added 4914.29%
|
|
|
|
CALL
|
$0
|
2.58M
|
Q3 2024
Added 637.73%
|
|
|
|
PUT
|
$0
|
154K
|
Q3 2024
Added 3660.98%
|
|
|
|
CALL
|
$0
|
4.9K
|
Q3 2024
Reduced 57.39%
|
|
|
|
CALL
|
$0
|
300
|
Q3 2024
Reduced 50.0%
|
|
|
|
PUT
|
$0
|
6K
|
Q3 2024
New holding
|
|
|
|
CALL
|
$0
|
28.3K
|
Q3 2024
Added 322.39%
|
|
|
|
PUT
|
$0
|
31K
|
Q3 2024
Added 146.03%
|
|
|
|
CALL
|
$0
|
200
|
Q3 2024
New holding
|
|
|
|
PUT
|
$0
|
7.1K
|
Q3 2024
Reduced 1.39%
|
|
|
|
CALL
|
$0
|
8.9K
|
Q3 2024
Added 122.5%
|
|
|
|
PUT
|
$0
|
186K
|
Q3 2024
Added 1109.09%
|
|
|
|
CALL
|
$0
|
93.4K
|
Q3 2024
Added 20.36%
|
|
|
|
PUT
|
$0
|
31.5K
|
Q3 2024
Reduced 11.52%
|
|
